Easywell Biomedicals, Inc.

TPEX:1799 Stock Report

Market Cap: NT$8.9b

Easywell Biomedicals Past Earnings Performance

Past criteria checks 0/6

Easywell Biomedicals has been growing earnings at an average annual rate of 5.8%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 10.2% per year.

Key information

5.8%

Earnings growth rate

16.0%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate-10.2%
Return on equity-22.4%
Net Margin-39.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 12
What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Revenue & Expenses Breakdown

How Easywell Biomedicals makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:1799 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24361-14196293
31 Mar 24308-14481284
31 Dec 23272-14562271
30 Sep 23241-14630250
30 Jun 23215-14526224
31 Mar 23181-15823215
31 Dec 22179-16128209
30 Sep 22149-15927213
30 Jun 22149-18425227
31 Mar 22161-20826235
31 Dec 21197-15024238
30 Sep 21247-12724224
30 Jun 21240-13025216
31 Mar 21261-12324222
31 Dec 20268-17321222
30 Sep 20269-24421233
30 Jun 20314-24223232
31 Mar 20354-23925222
31 Dec 19360-24226225
30 Sep 19420-14030216
30 Jun 19434-11228220
31 Mar 19411-11030221
31 Dec 18419-10434210
30 Sep 18343-19139245
30 Jun 18346-24442273
31 Mar 18370-26047285
31 Dec 17374-29254308
30 Sep 17407-32268288
30 Jun 17439-30586260
31 Mar 17401-29296231
31 Dec 16328-255104183
30 Sep 16314-19897152
30 Jun 16266-16390116
31 Mar 16363-1448596
31 Dec 15468-1458289
30 Sep 15530-1149072
30 Jun 15486-1168258
31 Mar 15337-977442
31 Dec 14227-856228
30 Sep 1494-1455430
30 Jun 1485-1325134
31 Mar 1496-1374839
31 Dec 13100-1324548

Quality Earnings: 1799 is currently unprofitable.

Growing Profit Margin: 1799 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1799 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.8% per year.

Accelerating Growth: Unable to compare 1799's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1799 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).


Return on Equity

High ROE: 1799 has a negative Return on Equity (-22.45%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies